The Molecular Medicine Program

Recent developments in Genomic Sciences have provided new conceptual frameworks and technological tools for the genetic classification of cancer and the discovery of novel approaches to its prevention, diagnosis and treatment. IEO has launched a Molecular Medicine Program, located within the IEO building, whose primary goals are the development of translational research and the creation of an active interface between the basic research programs of the IFOM-IEO Campus and the IEO clinical activities.
Major objectives of the Molecular Medicine Programs are: potentiation of the Tumor Bank and Tumor Registry, promotion of Phase 0 clinical trials for the rapid screening of new drugs, personalization of patient stratification and treatment through the use of genomic screens, as well as stem cell research and therapy.